Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

Wellington Cancer Centre, Wellington Hospital, Wellington

Auckland City Hospital, Auckland

Macquarie University Hospital, Macquarie University

Gosford Hospital, Gosford

Lake Macquarie Private Hospital, Gateshead

Shoalhaven Cancer Care Centre, Nowra

Southern Highlands Cancer Centre, Bowral

Victorian Breast and Oncology Care, East Melbourne

Alfred Hospital, Melbourne

Sunshine Hospital, St Albans

The Northern Hospital, Epping

Frankston Hospital, Frankston

Royal Brisbane and Womens Hospital, Herston

Toowoomba Hospital, Toowoomba

Sunshine Coast University Hospital, Birtinya

Fiona Stanley Hospital, Murdoch

St John of God Bunbury, Bunbury

Canberra Hospital, Garran

BCCA - Cancer Centre for the Southern Interior, Kelowna

BCCA - Fraser Valley Cancer Centre, Surrey

BCCA - Vancouver Cancer Centre, Vancouver

Regional Health Authority B, Zone 2, Saint John

QEII Health Sciences Centre, Halifax

Royal Victoria Regional Health Centre, Barrie

William Osler Health System, Brampton

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

Kingston Health Sciences Centre, Kingston

London Regional Cancer Program, London

Stronach Regional Health Centre at Southlake, Newmarket

Ottawa Hospital Research Institute, Ottawa

Algoma District Cancer Program, Sault Ste. Marie

Thunder Bay Regional Health Sciences Centre/, Thunder Bay

University Health Network, Toronto

Windsor Regional Cancer Centre, Windsor

Centre Integre de Sante et de Services Sociaux, Greenfield Park

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

CHA-Hopital Du St-Sacrement, Québec

Allan Blair Cancer Centre, Regina

Saskatoon Cancer Centre, Saskatoon